Betmiga 50mg Tablet

By Betmiga

Rx

10 Tablet in a Strip

Composition icon

Composition

Mirabegron(50mg)

Manufacturer - Astellas Pharma Inc icon

Manufacturer - Astellas Pharma Inc

Astellas Pharma India Pvt Ltd, 301, 3rd Floor, C and B Square, 127 Andheri Kurla Road, Chakala, Andheri East, Mumbai 400 069.

Expires on or after icon

Expires on or after

January, 2027

About Betmiga 50mg Tablet

Betmiga 50mg Tablet is a medication that is used to address the symptoms associated with an overactive bladder. These symptoms may include an increased frequency of urination, a sudden and urgent need to urinate, and difficulty controlling urination. The tablet functions by relaxing the muscles surrounding the bladder, thereby enhancing its capacity to store urine effectively.

It is important to adhere to the prescribed dosage and duration when taking Betmiga 50mg Tablet. The medication can be taken with or without food by swallowing it whole, without crushing or chewing it. It is crucial not to discontinue the medication without consulting your healthcare provider, as this action could result in a deterioration of your symptoms. Completing the full course of treatment is essential for the optimal efficacy of the medicine.

Common side effects that may be experienced while taking Betmiga 50mg Tablet include constipation, headache, high blood pressure, nasal inflammation, urinary tract infections, rapid heartbeat, and joint pain. If any of these side effects are bothersome or persistent, it is advisable to seek medical advice promptly.

Prior to commencing treatment with Betmiga 50mg Tablet, it is essential to inform your doctor about any other medications you may be taking for pre-existing health conditions. Additionally, pregnant or breastfeeding individuals should disclose this information to their healthcare provider before initiating treatment. Patients with liver or kidney diseases should exercise caution when taking the prescription and should follow up regularly as advised by their doctor.


Benefits

Betmiga 50mg Tablet is a medication that offers several benefits in the treatment of Overactive Bladder (OAB) symptoms. It works by targeting the uncontrollable contractions of the bladder muscles that lead to symptoms such as frequent urination, urgent need to urinate, and inability to control the passing of urine. By effectively managing these spasms, Betmiga 50mg Tablet helps in reducing the urgency to urinate that can be experienced, especially in cases of urinary tract infections. This medication is designed to relieve the discomfort associated with painful or frequent urination, ultimately offering relief and improved quality of life for individuals dealing with OAB symptoms.


Containing the active ingredient mirabegron, Betmiga 50mg Tablet falls under the class of medications known as anticholinergics. Mirabegron works by decreasing the activity of the overactive bladder, addressing the root cause of the condition. In cases of OAB, the muscle contractions in the bladder happen prematurely, leading to frequent urges to urinate. By inhibiting these sudden contractions of the bladder muscles, Betmiga 50mg Tablet enables better control over urination and increases the bladder's capacity to hold urine. This not only helps in managing the symptoms of OAB efficiently but also empowers individuals to regain control over their bladder function, improving their overall well-being and confidence.


In conclusion, Betmiga 50mg Tablet offers significant benefits in the treatment of Overactive Bladder symptoms by targeting and managing the underlying causes of the condition. With its ability to alleviate the discomfort associated with OAB symptoms and provide relief from frequent urges to urinate, Betmiga 50mg Tablet plays a vital role in enhancing the quality of life for individuals struggling with bladder control issues.


How to use the Betmiga 50mg Tablet

To properly use Betmiga 50mg Tablet, follow the instructions given by your doctor. Swallow the tablet whole with a glass of water. Do not chew, crush, or break the tablet. You can take Betmiga 50mg Tablet with or without food, but try to take it at the same time every day. Your doctor will determine the appropriate dosage based on factors like your age, weight, and medical condition. It is important to strictly follow your doctor's recommendations for the best results. If you are using the suspension or drops form of Betmiga, shake the bottle well before use and measure the dose using the provided measuring cup, dosing syringe, or dropper. For granules for suspension, follow the directions on the label. Tap the bottle to loosen the granules, add water, shake, and let it stand before shaking again until the granules have dispersed. Take the prescribed dose as instructed by your doctor. If you have any questions about how to use Betmiga 50mg Tablet, consult your healthcare provider for guidance.


Uses of Betmiga 50mg Tablet

Betmiga 50mg Tablet is primarily used for treating symptoms of Overactive Bladder (OAB). This condition is characterized by urinary incontinence (loss of bladder control). The tablet is specifically designed to address OAB symptoms such as urge urinary incontinence, urgency, and frequent urination. Betmiga 50mg Tablet can help manage these symptoms effectively, providing relief to individuals dealing with OAB.


What conditions Betmiga 50mg Tablet treats?

In overactive bladder (OAB), the bladder muscles contract too soon, leading to frequent urges to urinate. Normally, the bladder contracts only when it's full, signaling the brain for urination. But in OAB, this process is disrupted, causing an individual to feel the need to urinate even when the bladder isn't full yet.


Should you consult a doctor?

If you experience severe side effects such as allergic reactions like rash, itching, swelling, dizziness, or trouble breathing, it is essential to seek medical help immediately. Contact a doctor if you notice signs of a urinary tract infection like pain or burning during urination, frequent urination, or blood in the urine. Seeking medical attention is important if you have difficulty emptying your bladder completely or if you experience any new or worsening symptoms while taking Betmiga 50mg Tablet. If you have a history of certain medical conditions like liver or kidney problems, it's important to consult a doctor before starting this medication. Additionally, if you are pregnant, planning to become pregnant, or breastfeeding, seek medical advice before using Betmiga to ensure the safety of both you and your baby.


Side effects of Betmiga 50mg Tablet

When taking Betmiga 50mg Tablet, you may experience some side effects as your body gets used to the medicine. These side effects are usually not serious and may go away on their own. Common side effects of Betmiga 50mg Tablet include constipation, headache, high blood pressure, nasal inflammation, urinary tract infection, fast heart rate, and joint pain. You may also experience nausea, diarrhea, dizziness, and an increased heart rate.


Some less common side effects that may occur include signs of bladder infection such as frequent urge to urinate, burning sensation during urination, and blood in the urine. Other side effects may include indigestion, stomach infection, joint swelling, itching in the vulva or vagina, skin rash with red bumps, itching, and inflammation of small blood vessels in the skin.


In rare cases, more serious side effects may occur, such as irregular and rapid heartbeat (atrial fibrillation) or a sudden throbbing headache similar to migraine. If you experience any of these serious side effects, stop taking Betmiga 50mg Tablet immediately and contact your doctor for further advice. It's important to consult your doctor if any side effects persist or if you have any concerns about the medication.


Safety advice

scroll

liver

When taking Betmiga 50mg Tablet, it is important to be cautious if you have liver disease. It may be necessary to adjust the dosage of the medication, so it is crucial to consult your doctor before starting treatment. If you have severe liver disease, it is not recommended to use Betmiga 50mg Tablet. Always seek medical advice and guidance to ensure the safe use of this medication in relation to any liver issues.

scroll

kidney

Betmiga 50mg Tablet requires caution if you have severe kidney disease. Your doctor may need to adjust your dosage. Always consult your doctor before using Betmiga 50mg Tablet.

scroll

alcohol

When taking Betmiga 50mg Tablet, it is important to be cautious when consuming alcohol. It is recommended to consult your doctor regarding alcohol intake while on this medication.

scroll

driving

Betmiga 50mg Tablet typically does not impact your driving ability.

scroll

pregnancy

Betmiga 50mg Tablet may not be safe to use during pregnancy. Animal studies suggest potential harm to the developing baby. Consult your doctor for a thorough evaluation of the benefits and risks before taking this medication.

scroll

breastfeeding

Betmiga 50mg Tablet may be unsafe during breastfeeding. Limited data indicates potential harm to the baby as the drug might pass into breastmilk.


Age above 75(Geriatrics)

Betmiga 50mg Tablet can be used in elderly patients with caution. However, consult your doctor before taking the medicine.


Age below 6 months(Pediatrics)

The safety and effectiveness of Betmiga 50mg Tablet in pediatric patients have not been established. Consult your doctor before taking the medicine.


Consumption warning before consuming Betmiga 50mg Tablet

Before using Betmiga 50mg Tablet, do not take it if you are allergic to any of its ingredients. Inform your doctor if you have kidney or liver disease, hypertension, urinary retention, angioedema, or a history of heart rhythm problems. If you are pregnant or breastfeeding, consult your doctor before taking this medication. Be cautious while driving or operating heavy machinery, as Betmiga 50mg Tablet may cause dizziness.


Disease interactions

When taking Betmiga 50mg Tablet, it is important to be cautious if you have certain health conditions. Patients with urinary retention, which is the inability to urinate, should useBetmiga 50mg Tablet with care. Similarly, individuals with heart rhythm issues like QT prolongation, hypertension (high blood pressure), those undergoing kidney dialysis, and those with severe liver or kidney disease should also approach Betmiga 50mg Tablet with caution. It is crucial for patients with these conditions to consult their healthcare provider before starting Betmiga 50mg Tablet to ensure proper management and monitoring of potential interactions.


What if you forgot to take Betmiga 50mg Tablet?

If you forget to take your Betmiga 50mg Tablet, take it as soon as you remember. However, if it's close to your next scheduled dose, just skip the missed one and continue with your regular dosing schedule. Avoid taking a double dose to make up for the missed one. It's important to stick to the prescribed dosage to maintain the effectiveness of the medication.


What happens if you take overdose of Betmiga 50mg Tablet?

In case of accidental ingestion of an excessive amount of Betmiga 50mg Tablet, it is crucial to seek urgent medical attention. Signs of an overdose may include a higher heart rate or elevated blood pressure. It is recommended to contact your healthcare provider or go to the nearest hospital promptly for proper evaluation and management.


Related lab tests

The Related Lab Tests for Betmiga 50mg Tablet usually includes tests such as Urine Routine & Microscopy. These tests are commonly done to monitor the effects of the medication on the urinary system. The Urine Routine test helps in evaluating the physical, chemical, and microscopic properties of urine, including color, appearance, pH levels, and presence of any abnormalities such as blood cells or bacteria. The Microscopy test involves examining urine samples under a microscope to detect any irregularities like crystals, casts, or abnormal cells. These lab tests are important to assess the kidney function and overall health of the urinary tract while taking Betmiga 50mg Tablet.


Additional Information

Habit FormingNo
Chemical ClassAnilide Derivative
Therapeutic ClassUROLOGY
Action ClassSelective beta 3-adrenoceptor agonist (Bladder)

FAQs


Disclaimer

The information provided on this website is to the best of our abilities to ensure it is accurate, reliable, and reviewed by a team of professionals. It should not be used to diagnose, prevent, or cure any health problem. The information presented here is not intended to create a doctor-patient relationship or replace a registered medical practitioner's advice, diagnosis, or treatment. The absence or provision of any information or warning regarding any medicine should not be assumed as an implied or explicit assurance of safety or efficacy. We highly recommend consulting your registered medical practitioner for all queries or doubts related to your medical condition. Do not ignore professional medical advice or delay seeking it based on the content encountered on our website. We intend to support, not replace, the doctor-patient relationship.

1066

Inclusive of all taxes

Content verified by

chevron-right

Dr. Upasana Bhatia

MBBS - General Medicine

Last update on 01-Oct-2024